“…A majority of clinical trials report the use of additional amplification to increase audibility of low frequency sound in cases of reduced hearing thresholds in this region (Gantz et al, 2005;Gantz et al, 2006;Gstoettner et al, 2009;Kiefer et al, 2004;Kiefer et al, 2005;Kong et al, 2005;Luetje et al, 2007;Turner et al, 2004). However, details regarding the use of this amplification such as how many participants received amplification, what hearing loss was considered appropriate for additional amplification, whether it was provided through a separate hearing aid device or through a hybrid cochlear implant device, and what fitting procedures were used, was usually not clearly specified.…”